Merck Plans To ‘Tuck In’ Imago And Its Phase III-Ready Hematologic Candidate

 
• By Joseph Haas
Myeloproliferative neoplasms
Merck will acquire Imago's lead candidate for myeloproliferative neoplasms • Source: Shutterstock

More from Deals

More from Business